Get startedLog in
    Picture of Ryvu Therapeutics SA logo

    RVU — Ryvu Therapeutics SA News Story

    0.000.00%
    pl flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Ryvu Therapeutics Withdraws From Grant Agreement To Identify PRMT5 Inhibitor Markers

    Picture of Ryvu Therapeutics SA logoRyvu Therapeutics SA
    08/04/2025 16:05
    April 8 (Reuters) - Ryvu Therapeutics SA RVU.WA:

WITHDRAWS FROM GRANT AGREEMENT WITH MEDICAL RESEARCH AGENCY FOR IDENTIFICATION OF MARKERS TO SELECT PATIENTS FOR PRMT5 INHIBITOR THERAPY

DECISION DUE TO CHANGE IN RESEARCH SCOPE TOWARDS BRAIN TUMORS

Source text: ID:nEMFFrlJa

Further company coverage: RVU.WA

 (Reporting by Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Ryvu Therapeutics SA

    See all news